Skip to content

Drug interactions

Buprenorphine long-acting + Midazolam

Severity: Major

Buprenorphine long-acting and Midazolam: major interaction.

Last updated Sources: US FDA label

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Concomitant use of long-acting injectable buprenorphine with midazolam increases the risk of profound sedation, respiratory depression, coma and death. Buprenorphine levels persist for weeks, so the interaction risk is prolonged.

What this interaction means in plain words

Buprenorphine long-acting and Midazolam can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Evidence level: High

Why it happens

Additive CNS and respiratory depression from partial mu-opioid agonism and GABA-A potentiation.

What to do

Reserve combined use for patients without alternatives and use the lowest midazolam dose needed. Monitor respiratory rate and sedation level closely.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Buprenorphine long-acting and Midazolam, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

References

Frequently asked questions

Can I take Buprenorphine long-acting with Midazolam?

MediHelp rates the interaction as major. Buprenorphine long-acting and Midazolam can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Concomitant use of long-acting injectable buprenorphine with midazolam increases the risk of profound sedation, respiratory depression, coma and death. Buprenorphine levels persist for weeks, so the interaction risk is prolonged.

How serious is the interaction between Buprenorphine long-acting and Midazolam?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Reserve combined use for patients without alternatives and use the lowest midazolam dose needed. Monitor respiratory rate and sedation level closely.

What other medicines interact with Midazolam?

MediHelp also lists interactions of Midazolam with, for example, Atazanavir, Cobicistat, Darunavir. The full list is on the Midazolam page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in